EIKN
Eikon Therapeutics, Inc. Common Stock • NASDAQ
$13.78 ▲ 1.03% (+0.14)
EIKN
Eikon Therapeutics, Inc. Common StockNASDAQ • $13.78 ▲ 1.03% (+0.14)
Market Cap $40.66 M
52w High $17.40
52w Low $13.29
P/E -2.33
Volume 270.80K
Outstanding Shares 2.95M
Market Cap $40.66 M
52w High $17.40
52w Low $13.29
P/E -2.33
Volume 270.80K
Outstanding Shares 2.95M
About Eikon Therapeutics, Inc. Common Stock
https://eikontx.comEikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops innovative medicines to address serious unmet medical needs. It develops a platform that permits precise characterization of protein interactions in living cells.
CEO
Roger Perlmutter
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public February 5, 2026
Method of going public IPO
Full time employees 0
ETFs Holding This Stock
Summary
Total 1
Showing Top 1 of 1
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0